cmAngio® vs Huxley SANSA Home Sleep Apnea Test (1000-00)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CureMetrix
VS

AI Verdict

Tool A specializes in leveraging AI to detect Breast Arterial Calcifications on mammograms, offering insights into cardiovascular risk through existing imaging data. In contrast, Tool B is an AI-powered wearable designed for home diagnosis of sleep apnea and cardiac arrhythmias by analyzing physiological data. While both contribute to cardiovascular health, they address different diagnostic needs and utilize distinct data sources and workflows.

Choose cmAngio® if…

Choose cmAngio® if your clinical goal is to integrate cardiovascular risk assessment into routine breast cancer screening workflows, leveraging existing mammography images to identify Breast Arterial Calcifications (BAC) without additional patient procedures. This tool is ideal for enhancing women's health initiatives by providing early insights into potential cardiovascular disease risk during standard mammogram interpretation.

View cmAngio® →

Choose Huxley SANSA Home Sleep Apnea Test (1000-00) if…

Choose Huxley SANSA if you need a streamlined, app-free solution for home-based diagnosis of sleep apnea and cardiac arrhythmias, especially for patients who benefit from multi-day monitoring or prefer a simple, wearable device with built-in cellular data upload. This tool is well-suited for expanding access to cardiosleep diagnostics and reducing the burden of traditional in-lab sleep studies.

View Huxley SANSA Home Sleep Apnea Test (1000-00) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature cmAngio® Huxley SANSA Home Sleep Apnea Test (1000-00)
Pricing Paid, out-of-pocket Unknown
Deployment Cloud-based, integrates with any DICOM-compliant viewer Cloud-native platform, accessible from any browser.
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature cmAngio® Huxley SANSA Home Sleep Apnea Test (1000-00)
Name cmAngiou00ae Huxley SANSA Home Sleep Apnea Test (1000-00)
Company CureMetrix Huxley Medical
Description FDA-cleared AI software for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment. FDA-cleared, AI-powered wearable patch for home sleep apnea and cardiac arrhythmia diagnosis, offering an app-free, cellular-enabled solution for streamlined patient care.
Primary Function AI-based detection of Breast Arterial Calcifications (BAC) Home sleep apnea and cardiac arrhythmia diagnosis
Key Feature 1 AI-based detection of Breast Arterial Calcifications (BAC) Wearable chest patch design
Key Feature 2 Processes both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams App-free workflow
Key Feature 3 Provides visualization of BAC location on a scorecard Built-in cellular data upload

Videos

Demos, reviews, and walkthroughs featuring cmAngio® and Huxley SANSA Home Sleep Apnea Test (1000-00).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

cmAngiou00ae is FDA-cleared AI software for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment. Huxley SANSA is an FDA-cleared, AI-powered wearable patch designed for home diagnosis of sleep apnea and cardiac arrhythmias.
cmAngiou00ae processes existing Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams, integrating with DICOM-compliant viewers without requiring additional radiation or procedures. Huxley SANSA utilizes a wearable chest patch that collects 9 physiological data channels and uploads data via a built-in cellular connection, offering an app-free workflow for patients.
cmAngiou00ae is relevant for Cardiology, Obstetrics & Gynecology, and Radiology, as it provides cardiovascular risk insights from mammograms. Huxley SANSA is primarily for Cardiology, Pulmonology, and Sleep Medicine, focusing on cardiosleep diagnosis.
cmAngiou00ae offers AI-based detection and visualization of BAC location on a scorecard, compatible with any DICOM viewer and featuring an adjustable operating point. Huxley SANSA provides a wearable chest patch with 9 physiological data channels (including ECG, SpO2, and sleep staging), AI-powered auto-scoring, multi-day monitoring, and built-in cellular data upload.
cmAngiou00ae is designed for quick and easy installation (less than an hour) and integrates with existing mammography workflows, providing BAC identification and reporting without additional procedures. Huxley SANSA streamlines cardiosleep diagnosis with a direct-to-patient, app-free, cellular-enabled solution, simplifying data collection and reducing patient interaction complexities.
Both cmAngiou00ae and Huxley SANSA are FDA-cleared and HIPAA-compliant. For cmAngiou00ae, physicians need to contact the vendor for Business Associate Agreement (BAA) details, while Huxley SANSA explicitly states it has a BAA.

Backers

Who funded each tool's parent company.

cmAngio®

AI Tool Finder
AI-powered search. Results may not be comprehensive.